Philip Drake February 26, 2019 Corporate Innovation Pharmaceuticals Forms Irish Subsidiary to Facilitate International Development of Clinical Pipeline
Philip Drake January 31, 2019 Corporate Innovation Pharmaceuticals Establishing European Subsidiary; CEO Increases Equity Stake in IPIX
Philip Drake November 8, 2018 Corporate Innovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline Priorities
Philip Drake October 9, 2018 Corporate Innovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical Pipeline
Philip Drake September 20, 2018 Corporate Innovation Pharmaceuticals Provides Corporate Update Highlighting Upcoming Milestones and Events
Philip Drake June 28, 2018 Corporate Innovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire Capital
Philip Drake September 11, 2017 Corporate Innovation Pharmaceuticals Secures New $30 Million Common Stock Purchase Agreement
Philip Drake August 15, 2017 Corporate Innovation Pharmaceuticals to Discuss Recent Positive Clinical Results in IBD and Upcoming Milestones in Oral Mucositis and Psoriasis Trials at BioCentury’s “NewsMakers” Conference
Philip Drake June 9, 2017 Corporate Innovation Pharmaceuticals Name and Ticker Change Effective, Replay of Shareholder Conference Call Available
Philip Drake June 7, 2017 Corporate Cellceutix Announces Company Name Change to Innovation Pharmaceuticals Inc.
Philip Drake May 10, 2017 Corporate Cellceutix Provides Corporate Update; Significant Milestones Ahead as Multiple Mid-Phase Clinical Trials Set to Conclude
Philip Drake April 19, 2017 Corporate Cellceutix Announces Details for Upcoming Shareholder and Investor Presentations
Philip Drake February 16, 2017 Corporate Cellceutix Reports on Q2 Fiscal 2017, Prepares for Important Clinical Milestones
Philip Drake January 17, 2017 Corporate Cellceutix Strongly Denounces Criminal Enterprise Mako Research, Who Published “Fake News” Full of Lies and Innuendo
Philip Drake January 4, 2017 Corporate, Brilacidin Cellceutix to Present at Biotech Showcase 2017; Brilacidin for Oral Mucositis Nears Interim Results
Philip Drake December 22, 2016 Corporate Cellceutix Wishes Shareholders Happy Holidays, Prepares for 2017 Focused on Partnerships
Philip Drake November 14, 2016 Corporate Cellceutix Provides Corporate Update and Reports Q1 Fiscal 2017 Financial Results
Philip Drake November 9, 2016 Corporate Cellceutix Announces Business Update Call at 10AM Eastern on November 15
Daniel Pizza September 16, 2016 Corporate Cellceutix Announces Appointment of Vice President for Regulatory Affairs
